Yüklüyor......
Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome
Metabolic syndrome (MetS), the co-occurrence of obesity, hypertension, hyperglycemia and dyslipidema, is an important risk factor for diabetes, cardiovascular disease and end-organ damage in the brain. Our goal was to determine if metabolic syndrome (MetS) differentially affects cerebral metabolism...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3614081/ https://ncbi.nlm.nih.gov/pubmed/22552897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-012-9306-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|